Zhang Lab

National University of Singapore

Home Research COVID-19 Services Publications People Teaching Job Opening News Forum Lab Only

Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

GLASS

You can:

Go to the GPCR, ligand, or experimental data tables.
Go to the experimental data table for text mining information in PubMed ID column.
Go to the GPCR page and check other ligands which interact with it.
Go to the ligand page and check other GPCRs which it interacts with.
Go back to previous page.

GPCR

Name	5-hydroxytryptamine receptor 1A
Species	Homo sapiens (Human)
Gene	HTR1A
Synonym	5-HT-1A 5-HT1A serotonin receptor 1A 5-HT1A receptor 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled Gpcr18 ADRB2RL1 ADRBRL1 G-21 [ Show all ]
Disease	Urinary incontinence Generalized anxiety disorder Generalized anxiety disorder; Social phobia Hypertension Hypoactive sexual desire disorder Major depressive disorder Major depressive disorder; Episode; Anxiety Migraine Mood disorder Pain Parkinson's disease Premature ejaculation Psychiatric disorder Psychotic disorders Schizoaffective disorder; Schizophrenia Severe mood disorders Unspecified Female sexual dysfunction Eating disorder Schizophrenia Alzheimer disease Alzheimer disease; Peripheral sensory neuropathies; Lateral sclerosis Bulimia nervosa; Severe mood disorders Cervical dystonia; Spasm Cognitive disorders Anxiety disorder Depression Coronary artery disease [ Show all ]
Length	422
Amino acid sequence	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ
UniProt	P08908
Protein Data Bank	N/A
GPCR-HGmod model	P08908
3D structure model	This predicted structure model is from GPCR-EXP P08908.
BioLiP	N/A
Therapeutic Target Database	T78709
ChEMBL	CHEMBL214
IUPHAR	1
DrugBank	BE0000291

Ligand

Name	MDMA
Molecular formula	C11H15NO2
IUPAC name	1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine
Molecular weight	193.246
Hydrogen bond acceptor	3
Hydrogen bond donor	1
XlogP	2.2
Synonyms	FT-0693477 LS-34696 Midomafetamine [USAN] Phenethylamine, N,alpha-dimethyl-3,4-methylenedioxy- [1-(2H-1,3-benzodioxol-5-yl)propan-2-yl](methyl)amine (+-)-N-Methyl-3,4-(methylenedioxy)amphetamine 1-(1,3-Benzodioxol-5-yl)-N-methyl-2-propanamine CCRIS 9277 I14-2777 MDMA (unspecified) NCGC00168266-01 SCHEMBL44210 (+/-)-MDMA solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material 3,4-Methylenedioxy-N,alpha-dimethyl-beta-phenylethylamine 69610-10-2 CHEMBL43048 DivK1c_000962 Ecstasy (Drug) KE1SEN21RM Midomafetamine PDSP1_001522 XTC (+-)-(3,4-Methylenedioxy)methamphetamine 1,3-Benzodioxole-5-ethanamine, N,alpha-dimethyl- 3,4-methylenedioxymethylamphetamine BDBM50010588 D0F5NJ GTPL4574 Mandy [Street Name] N,alpha-Dimethyl-1,3-benzodioxole-5-ethanamine rac-3,4-Methylenedioxymethamphetamine (+/-)-(3,4-Methylenedioxy)methamphetamine 1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine 54946-52-0 CHEBI:1391 DB01454 IDI1_000962 Methylenedioxy Methamphetamine NCGC00168266-02 SHXWCVYOXRDMCX-UHFFFAOYSA-N (RS)-3,4-(methylenedioxy)methamphetamine 3,4-Methylenedioxy-N-methylamphetamine (MDMA) AC1L1BUR CTK5D0599 DL-(3,4-Methylenedioxy)methamphetamine Epitope ID:178091 LS-34695 Midomafetamine (USAN/INN) PDSP2_001506 XTC [Street Name] (+-)-N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane 1,3-Benzodioxole-5-ethanamine,N,a-dimethyl- 42542-10-9 C07577 D11172 HSDB 6929 N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE rac-MDMA (rac-3,4-Methylenedioxymethamphetamine) 1.0 mg/ml in Methanol (+/-)-3,4-METHYLENEDIOXYMETHAMPHETAMINE 3,4-MDMA 64057-70-1 (hydrochloride) DEA No. 7405 KBio1_000962 Methylenedioxymethamphetamine NINDS_000962 UNII-KE1SEN21RM ( inverted exclamation markA)-1,3-benzodioxolyl-N-methyl-2-propanamine( inverted exclamation markA)-3,4-methylenedioxy-N-methyl-\|A-methyl-2-phenethylamineDL-3,4-methylenedioxy-N-methylamphetaminemethylenedioxymethamphetamine 3,4-methylenedioxymethamphetamine AKOS006283463 D0EX3I Ecstasy [ Show all ]
Inchi Key	SHXWCVYOXRDMCX-UHFFFAOYSA-N
Inchi ID	InChI=1S/C11H15NO2/c1-8(12-2)5-9-3-4-10-11(6-9)14-7-13-10/h3-4,6,8,12H,5,7H2,1-2H3
PubChem CID	1615
ChEMBL	CHEMBL43048
IUPHAR	N/A
BindingDB	50010588
DrugBank	DB01454
Structure SDF download
Lipinski's druglikeness	This ligand satisfies Lipinski's rule of five.

Experimental Data

Parameter	Value	Reference	Database source
Ki	<10000.0 nM	PMID12761331, http://pdsp.med.unc.edu/pdsp.php, http://molpharm.aspetjournals.org/cgi/content/full/63/6/1223	PDSP,BindingDB

zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417